NEU 1.44% $19.78 neuren pharmaceuticals limited

Retas Skyclavs was one of the biggest in 2023 for $7.3bn US by...

  1. 2,162 Posts.
    lightbulb Created with Sketch. 536
    Retas Skyclavs was one of the biggest in 2023 for $7.3bn US by Biogen rare disease drug estimate 5,000 patients in US and $1.5bn sales 2030….. premium was only 60% on their share price at the time.

    2591 ‘s potential patients with only current x 4 indications is x 10 (as per presentations) that of Skyclavs with scope for many more potentially…..

    Retas deal x 10 is $10-15bn in sales 2030-2033 US only for the potential future of 2591 as a starting point. Likely $30 bn globally…

    Fairly attractive asset.


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.78
Change
0.280(1.44%)
Mkt cap ! $2.506B
Open High Low Value Volume
$19.49 $19.84 $19.25 $2.341M 119.3K

Buyers (Bids)

No. Vol. Price($)
3 83 $19.76
 

Sellers (Offers)

Price($) Vol. No.
$19.78 178 13
View Market Depth
Last trade - 13.11pm 17/06/2024 (20 minute delay) ?
Last
$19.83
  Change
0.280 ( 1.11 %)
Open High Low Volume
$19.41 $19.84 $19.25 38389
Last updated 13.31pm 17/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.